Active 0 6 0 6 B-chronic_disease
uncontrolled 7 19 7 19 I-chronic_disease
infection 20 29 20 29 I-chronic_disease

Aspartate 0 9 30 39 B-clinical_variable
aminotransferase 10 26 40 56 I-clinical_variable
( 27 28 57 58 I-clinical_variable
AST 28 31 58 61 I-clinical_variable
) 31 32 61 62 I-clinical_variable
or 33 35 63 65 O
alanine 36 43 66 73 B-clinical_variable
aminotransferase 44 60 74 90 I-clinical_variable
( 61 62 91 92 I-clinical_variable
ALT 62 65 92 95 I-clinical_variable
) 65 66 95 96 I-clinical_variable
> 67 68 97 98 O
5 69 70 99 100 B-lower_bound
times 71 76 101 106 I-lower_bound
upper 77 82 107 112 I-lower_bound
limit 83 88 113 118 I-lower_bound
of 89 91 119 121 I-lower_bound
normal 92 98 122 128 I-lower_bound
( 99 100 129 130 I-lower_bound
UNL 100 103 130 133 I-lower_bound
) 103 104 133 134 I-lower_bound

Bleeding 0 8 135 143 B-chronic_disease
diathesis 9 18 144 153 I-chronic_disease
, 18 19 153 154 O
not 20 23 155 158 O
correctable 24 35 159 170 O
by 36 38 171 173 O
usual 39 44 174 179 O
forms 45 50 180 185 O
of 51 53 186 188 O
therapy 54 61 189 196 B-treatment

Co 0 2 197 199 O
- 2 3 199 200 O
morbid 3 9 200 206 O
disease 10 17 207 214 O
of 18 20 215 217 O
condition 21 30 218 227 O
that 31 35 228 232 O
would 36 41 233 238 O
preclude 42 50 239 247 O
safe 51 55 248 252 O
delivery 56 64 253 261 O
of 65 67 262 264 O
TheraSphere 68 79 265 276 B-treatment
treatment 80 89 277 286 I-treatment
or 90 92 287 289 O
, 92 93 289 290 O
in 94 96 291 293 O
the 97 100 294 297 O
judgment 101 109 298 306 O
of 110 112 307 309 O
the 113 116 310 313 O
physician 117 126 314 323 O
, 126 127 323 324 O
place 128 133 325 330 O
the 134 137 331 334 O
patient 138 145 335 342 O
at 146 148 343 345 O
undue 149 154 346 351 O
risk 155 159 352 356 O

Diagnosis 0 9 357 366 O
of 10 12 367 369 O
intrahepatic 13 25 370 382 B-cancer
malignancy 26 36 383 393 I-cancer
including 37 46 394 403 O
but 47 50 404 407 O
not 51 54 408 411 O
limited 55 62 412 419 O
to 63 65 420 422 O
HCC 66 69 423 426 B-cancer
; 69 70 426 427 O
the 71 74 428 431 O
histopathology 75 89 432 446 O
confirmation 90 102 447 459 O
criterion 103 112 460 469 O
may 113 116 470 473 O
be 117 119 474 476 O
waived 120 126 477 483 O
in 127 129 484 486 O
patients 130 138 487 495 O
with 139 143 496 500 O
a 144 145 501 502 O
radiographically 146 162 503 519 O
identifiable 163 175 520 532 O
liver 176 181 533 538 O
mass 182 186 539 543 O
, 186 187 543 544 O
known 188 193 545 550 O
laboratory 194 204 551 561 O
or 205 207 562 564 O
clinical 208 216 565 573 O
risk 217 221 574 578 O
factors 222 229 579 586 O
for 230 233 587 590 O
cancer 234 240 591 597 B-cancer
or 241 243 598 600 O
elevated 244 252 601 609 O
tumor 253 258 610 615 B-cancer
markers 259 266 616 623 O
such 267 271 624 628 O
as 272 274 629 631 O
alpha 275 280 632 637 B-treatment
- 280 281 637 638 I-treatment
fetoprotein 281 292 638 649 I-treatment
( 293 294 650 651 I-treatment
AFP 294 297 651 654 I-treatment
) 297 298 654 655 I-treatment
and 299 302 656 659 O
clinical 303 311 660 668 O
findings 312 320 669 677 O

Eastern 0 7 678 685 B-clinical_variable
Cooperative 8 19 686 697 I-clinical_variable
Oncology 20 28 698 706 I-clinical_variable
Group 29 34 707 712 I-clinical_variable
( 35 36 713 714 I-clinical_variable
ECOG 36 40 714 718 I-clinical_variable
) 40 41 718 719 I-clinical_variable
performance 42 53 720 731 I-clinical_variable
status 54 60 732 738 I-clinical_variable
score 61 66 739 744 I-clinical_variable
0 67 68 745 746 B-lower_bound
- 69 70 747 748 O
2 71 72 749 750 B-upper_bound

Evidence 0 8 751 759 O
of 9 11 760 762 O
any 12 15 763 766 O
detectable 16 26 767 777 O
technetium-99 27 40 778 791 B-treatment
m 40 41 791 792 I-treatment
macroaggregated 42 57 793 808 I-treatment
serum 58 63 809 814 I-treatment
albumin 64 71 815 822 I-treatment
( 72 73 823 824 I-treatment
Tc-99 73 78 824 829 I-treatment
m 78 79 829 830 I-treatment
MAA 80 83 831 834 I-treatment
) 83 84 834 835 I-treatment
flow 85 89 836 840 O
to 90 92 841 843 O
the 93 96 844 847 O
stomach 97 104 848 855 O
or 105 107 856 858 O
duodenum 108 116 859 867 O
, 116 117 867 868 O
not 118 121 869 872 O
correctable 122 133 873 884 O
by 134 136 885 887 O
using 137 142 888 893 O
established 143 154 894 905 O
angiographic 155 167 906 918 B-treatment
techniques 168 178 919 929 O
to 179 181 930 932 O
stop 182 186 933 937 O
or 187 189 938 940 O
mitigate 190 198 941 949 O
such 199 203 950 954 O
flow 204 208 955 959 O

Evidence 0 8 960 968 O
of 9 11 969 971 O
potential 12 21 972 981 O
delivery 22 30 982 990 O
of 31 33 991 993 O
greater 34 41 994 1001 O
than 42 46 1002 1006 O
16.5 47 51 1007 1011 B-lower_bound
mCi 52 55 1012 1015 I-lower_bound
( 56 57 1016 1017 O
30 57 59 1017 1019 B-lower_bound
Gy 60 62 1020 1022 I-lower_bound
absorbed 63 71 1023 1031 O
dose 72 76 1032 1036 O
) 76 77 1036 1037 O
of 78 80 1038 1040 O
radiation 81 90 1041 1050 O
to 91 93 1051 1053 O
the 94 97 1054 1057 O
lungs 98 103 1058 1063 O
in 104 106 1064 1066 O
a 107 108 1067 1068 O
single 109 115 1069 1075 O
treatment 116 125 1076 1085 B-treatment

Evidence 0 8 1086 1094 O
of 9 11 1095 1097 O
pulmonary 12 21 1098 1107 B-chronic_disease
insufficiency 22 35 1108 1121 I-chronic_disease

History 0 7 1122 1129 O
of 8 10 1130 1132 O
severe 11 17 1133 1139 O
allergy 18 25 1140 1147 O
or 26 28 1148 1150 O
intolerance 29 40 1151 1162 O
to 41 43 1163 1165 O
any 44 47 1166 1169 O
contrast 48 56 1170 1178 B-allergy_name
media 57 62 1179 1184 I-allergy_name
, 62 63 1184 1185 O
narcotics 64 73 1186 1195 B-allergy_name
, 73 74 1195 1196 O
sedatives 75 84 1197 1206 B-allergy_name
, 84 85 1206 1207 O
or 86 88 1208 1210 O
atropine 89 97 1211 1219 B-allergy_name
that 98 102 1220 1224 O
can 103 106 1225 1228 O
not 106 109 1228 1231 O
be 110 112 1232 1234 O
corrected 113 122 1235 1244 O
or 123 125 1245 1247 O
premedicated 126 138 1248 1260 O

Ineligible 0 10 1261 1271 O
for 11 14 1272 1275 O
surgical 15 23 1276 1284 O
resection 24 33 1285 1294 B-treatment

Pregnancy 0 9 1295 1304 B-pregnancy

Serum 0 5 1305 1310 B-clinical_variable
bilirubin 6 15 1311 1320 I-clinical_variable
> 16 17 1321 1322 O
2.0 18 21 1323 1326 B-lower_bound
mg 22 24 1327 1329 I-lower_bound
/ 24 25 1329 1330 I-lower_bound
dl 25 27 1330 1332 I-lower_bound
( 28 29 1333 1334 O
unless 29 35 1334 1340 O
segmental 36 45 1341 1350 O
infusion 46 54 1351 1359 O
is 55 57 1360 1362 O
planned 58 65 1363 1370 O
) 65 66 1370 1371 O

Severe 0 6 1372 1378 O
peripheral 7 17 1379 1389 B-chronic_disease
vascular 18 26 1390 1398 I-chronic_disease
disease 27 34 1399 1406 I-chronic_disease
that 35 39 1407 1411 O
would 40 45 1412 1417 O
preclude 46 54 1418 1426 O
catheterization 55 70 1427 1442 B-treatment

Significant 0 11 1443 1454 O
extrahepatic 12 24 1455 1467 B-chronic_disease
disease 25 32 1468 1475 I-chronic_disease
representing 33 45 1476 1488 O
an 46 48 1489 1491 O
imminent 49 57 1492 1500 O
life 58 62 1501 1505 O
- 62 63 1505 1506 O
threatening 63 74 1506 1517 O
outcome 75 82 1518 1525 O

Significant 0 11 1526 1537 O
underlying 12 22 1538 1548 O
medical 23 30 1549 1556 O
or 31 33 1557 1559 O
psychiatric 34 45 1560 1571 B-chronic_disease
illness 46 53 1572 1579 I-chronic_disease

ny 0 2 1580 1582 O
contraindications 3 20 1583 1600 O
to 21 23 1601 1603 O
angiography 24 35 1604 1615 B-treatment
and 36 39 1616 1619 O
hepatic 40 47 1620 1627 B-treatment
artery 48 54 1628 1634 I-treatment
catheterization 55 70 1635 1650 I-treatment

